Radko Komers

Radko Komers

Company: Travere Therapeutics

Job title: Executive Director, Global Lead of Clinical Development Nephrology


Update on Sparsentan Development in Rare Kidney Diseases 3:30 pm

Summarizing available information from ongoing clinical trials with sparsentan in patients with IgA nephropathy and FSGS Exploring data in parallel with supporting preclinical evidence Navigating next steps in clinical development and beyond orphan drug designationRead more

day: Day Two

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.